Corrigendum to “Development and validation of a sensitive LC-MS/MS method for determination of gefitinib and its major metabolites in human plasma and its application in non-small cell lung cancer patients” [J. Pharm. Biomed. Anal. 2019 Aug 5:172:364–371]

Journal of Pharmaceutical and Biomedical Analysis · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles